Literature DB >> 9224687

Inhibition of Gal beta1, 4GlcNAc alpha2,6 sialyltransferase expression by antisense-oligodeoxynucleotides.

W Kemmner1, K Hohaus, P M Schlag.   

Abstract

Treatment of human colorectal carcinoma cells HT29 with specific antisense oligodeoxynucleotides led to a decreased Gal beta1,4GlcNAc alpha2,6 sialyltransferase activity on the level of protein expression as well as on the mRNA level. Antisense treatment did not effect cell viability or cell growth. Oligodeoxynucleotides which were complementary to the region upstream of the initiation codon were particularly effective in inhibition of enzyme expression. No such inhibition was found by treatment of cells with oligodeoxynucleotides complementary to the region downstream of the initiation codon or by treatment of cells with scrambled controls or sense oligodeoxynucleotides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224687     DOI: 10.1016/s0014-5793(97)00543-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.

Authors:  William R Alley; Milos V Novotny
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

2.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.

Authors:  T Petretti; W Kemmner; B Schulze; P M Schlag
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

3.  ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function.

Authors:  Daniel R Christie; Faheem M Shaikh; John A Lucas; John A Lucas; Susan L Bellis
Journal:  J Ovarian Res       Date:  2008-10-01       Impact factor: 4.234

4.  Gene silencing of β-galactosamide α-2,6-sialyltransferase 1 inhibits human influenza virus infection of airway epithelial cells.

Authors:  Dong Wu; Wenbo Huang; Yutao Wang; Wenda Guan; Runfeng Li; Zifeng Yang; Nanshan Zhong
Journal:  BMC Microbiol       Date:  2014-03-27       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.